Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake
Nucleic Acid Therapeutics · 2023
DOI: 10.1089/nat.2022.0062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, 2023. Verfasst von Sepideh Kaviani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Nanoparticles, Nucleic Acids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, McGill University, Montreal, Canada.
ORCID-Profile: Hassan H Fakih
Zitieren
APA
Kaviani, S., Fakih, H. H., Asohan, J., Katolik, A., Damha, M. J., & Sleiman, H. F. (2023). Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake. Nucleic Acid Therapeutics. https://doi.org/10.1089/nat.2022.0062
Vancouver
Kaviani S, Fakih HH, Asohan J, Katolik A, Damha MJ, Sleiman HF. Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake. Nucleic Acid Therapeutics. 2023. doi:10.1089/nat.2022.0062
BibTeX
@article{Kaviani2023,
author = {Kaviani, Sepideh and Fakih, Hassan H and Asohan, Jathavan and Katolik, Adam and Damha, Masad J and Sleiman, Hanadi F},
title = {Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake},
journal = {Nucleic Acid Therapeutics},
year = {2023},
doi = {10.1089/nat.2022.0062}
}
EUVIMED